SHELLEY AILANJIAN: Open Payments
NPI 1174741714 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$356 in 23 payments from 8 companies in 2025. Trend: 2023 $252 · 2024 $310 · 2025 $356
Food & beverage: $356
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 15 | $192 |
| Astellas Pharma US Inc | 2 | $44 |
| MILLICENT US INC | 1 | $23 |
| SHIELD THERAPEUTICS INC | 1 | $22 |
| Sage Therapeutics, LLC | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Evofem Biosciences, Inc. | 1 | $17 |
Products named: Veozah, FEMRING, ACCRUFER, ZURZUVAE, BOTOX, MYFEMBREE, Phexxi.
Industry payments across CA — which companies pay providers there.
